Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

NCT01116791 ·Status: TERMINATED ·Phase: PHASE2

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study

NCT03150628 ·Status: TERMINATED ·Phase: PHASE2

Combined Anticancer Treatment of Advanced Colon Cancer

NCT01540344 ·Status: TERMINATED ·Phase: PHASE2

Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach

NCT02829788 ·Status: UNKNOWN

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer

NCT03253939 ·Status: COMPLETED

HIPEC Using High Intra-abdominal Pressure

NCT02949791 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients

NCT02575859 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

NCT04180761 ·Status: WITHDRAWN ·Phase: PHASE2

Multivisceral Oncological Resections Involving the Pancreas - An International Multicenter Study

NCT07091097 ·Status: COMPLETED

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

NCT01617382 ·Status: RECRUITING

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

NCT04122885 ·Status: UNKNOWN

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

NCT01575730 ·Status: COMPLETED ·Phase: PHASE2

Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences

NCT01685632 ·Status: TERMINATED ·Phase: NA

The Intraoperative Physiologic Changes of Patients Under Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Cytoreductive Surgery; Prospective Observational Study

NCT02325648 ·Status: COMPLETED

ERAS® Guidelines Validation of CRS With or Without HIPEC

NCT05185791 ·Status: UNKNOWN

Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases

NCT01095523 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis

NCT02995850 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer

NCT01127815 ·Status: UNKNOWN

Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases

NCT03733184 ·Status: COMPLETED

Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)

NCT06057298 ·Status: UNKNOWN ·Phase: NA

Symptomatic and Incidental RCC Detection

NCT07004426 ·Status: COMPLETED

Thrombin Generation and Platelet Activation in CRS/HIPEC

NCT03034850 ·Status: COMPLETED

Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal Carcinomatosis

NCT06318793 ·Status: COMPLETED

The Role of the Vascular Surgeon in Oncologic Surgery of Abdominal and Pelvic Retroperitoneal Masses

NCT06803251 ·Status: RECRUITING

Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma

NCT05193006 ·Status: UNKNOWN